isoniazid has been researched along with cisatracurium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chen, L; Chen, Y; Han, Z; Hu, S; Liu, H; Liu, J; Ma, L; Sai, N; Wang, K; Wen, Q; Zhang, J; Zhang, Z; Zhou, C; Zhou, X | 1 |
2 other study(ies) available for isoniazid and cisatracurium
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cisatracurium besylate rescues Mycobacterium Tuberculosis-infected macrophages from necroptosis and enhances the bactericidal effect of isoniazid.
Topics: Animals; Anti-Bacterial Agents; Apoptosis; Isoniazid; Macrophages; Mice; Mycobacterium tuberculosis; Necroptosis; Protein Kinases; Receptor-Interacting Protein Serine-Threonine Kinases; Tuberculosis | 2023 |